Overview

Study of the Efficacy, Safety, and Pharmacokinetics of SM88 in Patients With Prostate Cancer

Status:
Completed
Trial end date:
2019-05-30
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety, pharmacokinetics, and efficacy of SM88 in patients with prostate cancer
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Tyme, Inc
Treatments:
Methoxsalen
Phenytoin
Sirolimus